@article{oai:iwate-u.repo.nii.ac.jp:00015778,
 author = {KOBATAKE, Yui and NAKATA, Kohei and SAKAI, Hiroki and SASAKI, Jun and YAMATO, Osamu and TAKASHIMA, Satoshi and NISHII, Naohito and MAEDA, Sadatoshi and ISLAM, Md Shafiqul and KAMISHINA, Hiroaki},
 issue = {9},
 journal = {Veterinary Sciences},
 month = {Sep},
 note = {Canine degenerative myelopathy (DM), recognized as a spontaneous model of amyotrophic lateral sclerosis, is known as a late-onset progressive degenerative disease of the spinal cord. Because of the progressive nature of DM, many dogs are elected to be euthanized, resulting in limited information on the end-stage clinical presentation. We investigated the long-term clinical course from diagnosis to natural death to further deepen our understanding of the entire clinical picture of this disease. Because curcumin was administered in some cases, the therapeutic effect of curcumin on DM was also examined. Forty dogs included in this study were client-owned Pembroke Welsh Corgis with a definitive diagnosis of DM by necropsy and histopathology. Dogs were excluded from this study if they died from another disease or were elected to be euthanized. Information on the long-term clinical symptoms of DM was investigated based on a questionnaire, which was collected from the dog owners. Urinary incontinence and respiratory disorder were observed in most dogs, as was respiratory impairment-correlated death. In contrast, signs consistent with brainstem dysfunction were noticed at the terminal stage in a small portion of dogs. Although further studies with more cases are needed, the results of this study suggest that administration of curcumin is effective in slowing the progression of DM.},
 title = {The long-term clinical course of canine degenerative myelopathy and therapeutic potential of curcumin},
 volume = {8},
 year = {2021}
}